References: J Am Osteopath Assoc February 1, 2011 vol
Side effects may include dry mouth, nausea, vomiting, and in severe cases, hallucinations or even death
Recommended starting dose: Discontinue other basal insulin and/or GLP-1 agonist before initiating Xultophy Patients nave to basal insulin or a GLP-1 agonist: starting dose is 10 units once daily Patients currently on basal insulin or a GLP-1 agonist: starting dose is 16 units once daily Maintenance: titrate dose up or down by 2 units once or twice weekly, depending on blood sugar goals Missed doses: resume dosing at the next scheduled dose
This cutting-edge treatment makes Honxi SMGT-GLP-1 Nano Microneedle Patch an ideal choice for type 2 diabetes patients and individuals looking to manage their weight effectively
A significant advantage of GLP-1 medications is their ability to change your relationship with food
Steady state provides more flexibility Once you reach steady state (four to five weeks for semaglutide, three to four weeks for tirzepatide), your body has a baseline level of medication that fluctuates within a predictable range